Paper · 6576184

Inhibition of anchorage-independent growth of human melanoma cells by a monoclonal antibody to a chondroitin sulfate proteoglycan.

Harper JR and 1 other. J Natl Cancer Inst, 1983. Cited by 73 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Inhibition of anchorage-independent growth of human melanoma cells by a monoclonal antibody to a chondroitin sulfate proteoglycan. Papers, record 6576184. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6576184

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Inhibition of anchorage-independent growth of human melanoma cells by a monoclonal antibody to a chondroitin sulfate proteoglycan.; PubMed
Journal: J Natl Cancer Inst; PubMed
Year: 1983; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/6576184/; PubMed
The journal: https://conductscience.org/library/journal-index/7503089; PubMed
Citations, by iCite: 73; iCite
Relative citation ratio, by iCite: 1.7; iCite
Revised in PubMed: 2010-11-18; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Harper JR	J R
2	Reisfeld RA	R A

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Antibodies, Monoclonal	Major topic
Chondroitin Sulfate Proteoglycans	Major topic
Melanoma	Major topic
Proteoglycans	Major topic
Antigen-Antibody Complex
Cell Adhesion
Cell Division
Cell Line
Clone Cells
Culture Media
DNA Replication
Humans

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
CA-28420	NCI NIH HHS	United States	R01CA028420	PubMed and NIH

Source NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMID	Title	Journal	Year	In Papers	Source
42,738,352	Proteoglycans as Regulators of Receptor Trafficking and Spatial Signaling in Cancer.	Cancers (Basel)	2026	https://conductscience.org/library/papers/42738352	PubMed
31,195,686	CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia.	Int J Mol Sci	2019	https://conductscience.org/library/papers/31195686	PubMed
30,635,633	NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.	Leukemia	2019	https://conductscience.org/library/papers/30635633	PubMed
28,657,611	CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL.	Biomedicines	2017	https://conductscience.org/library/papers/28657611	PubMed
22,004,131	CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.	Pigment Cell Melanoma Res	2011	https://conductscience.org/library/papers/22004131	PubMed
16,367,801	NG2-expressing cells in the nervous system: role of the proteoglycan in migration and glial-neuron interaction.	J Anat	2005	https://conductscience.org/library/papers/16367801	PubMed
8,970,159	NG2 proteoglycan and the actin-binding protein fascin define separate populations of actin-containing filopodia and lamellipodia during cell spreading and migration.	Mol Biol Cell	1996	https://conductscience.org/library/papers/8970159	PubMed
8,868,467	CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes.	Mol Biol Cell	1996	https://conductscience.org/library/papers/8868467	PubMed
8,790,396	Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.	Proc Natl Acad Sci U S A	1996	https://conductscience.org/library/papers/8790396	PubMed
8,354,696	Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels.	J Cell Biol	1993	https://conductscience.org/library/papers/8354696	PubMed

1 to 10 of 15

See all 15 cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
HLA-A	3,105	PubTator's text mining	https://conductscience.org/library/genes/3105	NCBI Gene
HLA-B	3,106	PubTator's text mining	https://conductscience.org/library/genes/3106	NCBI Gene
HLA-C	3,107	PubTator's text mining	https://conductscience.org/library/genes/3107	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6576184

GET https://conductscience.org/api/papers/v1/6576184/authors

API reference For AI assistants